AimedBio Emerges as a KOSDAQ Dark Horse with W2.8tr Market Cap on Debut Day [K-Bio Pulse]

• 임정요
• 2025.12.05
• 오전 07:50

Samsung Epis Holdings rebounds on new drug IND filing [K-Bio Pulse]

• 임정요
• 2025.12.04
• 오전 08:15

• pharmEdaily

Abion Surges on Bonus Stock Plan…SBioMedics Gains 19%[K-bio pulse]

• 김진수
• 2025.12.03
• 오전 08:15

• Korea’sbiotech
• HanAllBiopharma
• Peptron
• phamed

Trust Dividend for HanAll, Valuation Penalty for Peptron·Caregen[K-Bio Pulse]

• 유진희
• 2025.12.02
• 오전 08:15

• Kbiopulse
• PharmEdaily

Samyang Biopharm, T&R Biofab Surge…Peptron Volatile on Lilly Catalyst[K-Bio Pulse]

• 김새미
• 2025.12.01
• 오전 08:10

Vigencell Soars on Trial Win; Foreign Buying Lifts Nextbiomedical [K-Bio Pulse]

• 석지헌
• 2025.11.28
• 오전 09:18

• 팜이데일리
• 케어젠
• 바이젠셀
• 그래피

Graphy Jumps on Overhang Relief, Vigencell Soars on Phase 2 Win[K-Bio Pulse]

• 나은경
• 2025.11.27
• 오전 08:00

Samyang Biopharm Hits Second Straight Upper-Limit Gain [K-Bio Pulse]

• 김승권
• 2025.11.26
• 오전 10:44

• PharmEdaily
• Syntekabio
• AIdrug

SyntekaBio CEO, “No AI Drug Leader, a Chance for Us”

• 송영두
• 2025.11.25
• 오전 10:19

Paths divide for Samyang BioPharm and Epis Holdings [K-Bio Pulse]

• 임정요
• 2025.11.25
• 오전 08:18